Subscribe To
Medivolve closes previously announced secured convertible note financing for aggregate gross proceeds of $1.2m
Medivolve Inc. (NEO:MEDV.AQN, OTC:COPRF) said it has closed its previously announced secured convertibl...
January 12, 2023, 6:45 am
divo likely to outperform in a recessionary year
As stock market forecasts are bearish and recession looms, dividend-focused ETFs like Amplify CWP Enhanced Dividend Income ETF are likely to outperfor...
December 17, 2022, 12:03 am
divo: a must-own for income-seeking investors
Amplify CWP Enhanced Dividend Income ETF provides solid income with a low variance, making it suitable for long-term investors leaning on the conserva...
December 15, 2022, 3:01 pm
Tusimple, navistar end autonomous truck partnership
TuSimple Holdings and Navistar Inc. are going their separate ways. Their two-year marriage intended to birth a purpose-built Class 8 autonomous truck ...
December 6, 2022, 12:37 pm
Kanye west, kim kardashian finalize divorce settlement
and ‘s divorce was finalized on Tuesday, November 29, nearly two years after filing for ...
December 3, 2022, 9:00 pm
Etf of the week: amplify cwp enhanced dividend income etf (divo)
VettaFi's vice chairman Tom Lydon discussed the Amplify CWP Enhanced Dividend Income ETF (divo) on this...
November 23, 2022, 2:40 pm
Bristol myers (bmy) gains 24.2% ytd: what's in store for 2023?
Biotech giant Bristol Myers (BMY) outperforms the industry and the S&P 500 Index as Eliquis and Opdivo ...
November 21, 2022, 1:32 pm
Amplify cwp enhanced dividend income etf (divo) surpasses $2 billion in assets
Assets have doubled YTD in this high-quality equity income ETF CHICAGO, Nov. 16, 2022 (GLOBE NEWSWIRE) — Amplify ETFs is pleased to announce its act...
November 16, 2022, 11:00 am
Mansion global: tom brady and gisele bündchen finalize divorce and begin life as south florida neighbors
The model has snapped up an $11.5 million home in Surfside, Fla., that’s a stone’s throw from the under-construction mansion that it’s believed ...
November 12, 2022, 12:00 pm
Amplify adds divo sequel etf with international twist
The new fund has a similar strategy combining dividend-paying stocks with tactical covered calls....
September 9, 2022, 1:24 am
divo: very well positioned to deliver inflation-adjusted returns
The Amplify CWP Enhanced Dividend Income ETF has the right mix of exposure to large-cap companies and sectors that should outperform in the current in...
July 28, 2022, 2:24 am
Musk and twitter: from volatile courtship to messy divorce
Elon Musk's pursuit of Twitter was a melodrama from beginning to end—a volatile courtship between a mercurial billionaire and the massively influent...
July 9, 2022, 5:30 am
Apple's incomplete divorce from intel
The conversion from Intel to Apple Silicon has been a smashing success. But even the Mac Studio leaves something to be desired in graphics performance...
June 24, 2022, 3:11 am
Bristol myers' (bmy) opdivo combos get fda nod for escc
Bristol Myers (BMY) secures an FDA approval for two Opdivo-based regimens as the first-line treatment o...
May 30, 2022, 4:33 pm
divo etf: proving its worth in these bad times
divo is the Amplify CWP Enhanced Dividend Income ETF which uses a limited number of stocks to generate ...
May 25, 2022, 9:00 am
divo is a perfect etf for conservative and moderate portfolios
Amplify CWP Enhanced Dividend Income ETF is an attractive choice for portfolios with low to moderate risk tolerance. If the downtrend continues into t...
May 24, 2022, 4:51 pm
divo: strong dividend income etf, 5.2% yield, 7.7% dividend growth, moderate capital gains
divo is an actively-managed ETF investing in U.S. equities with strong dividends and dividend growth tr...
May 23, 2022, 4:48 am
This etf offers 2-pronged approach
Amplify's divo combines a dividend-paying equity strategy with tactical covered calls, and it's been st...
May 21, 2022, 5:29 pm
Bristol-myers squibb snags another approval for this mega-blockbuster drug
The EC has approved its cancer drug Opdivo, together with chemotherapy, to treat esophageal cancer....
May 7, 2022, 11:07 am
Bristol myers q1 earnings surpass street expectations, lowers fy22 guidance
Bristol-Myers Squibb Co (NYSE: BMY) has posted Q1 revenues of $11.65 billion, an increase of 5% Y/Y (7% constant currency), beating the consensus of...
April 29, 2022, 8:20 am